Burkitt leukemia

GPTKB entity

Statements (68)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:B-cell_ALL
gptkbp:affects B cells
gptkbp:associated_with gptkb:fandom
thrombocytopenia
infection risk
lymphadenopathy
painful lymph nodes
hepatomegaly
splenomegaly
abdominal mass
leukopenia
hyperuricemia
EBV infection
tumor lysis syndrome
bone marrow infiltration
central nervous system involvement
gastrointestinal involvement
jaw lesions
orbital involvement
skin involvement
testicular involvement
gptkbp:caused_by chromosomal translocation
gptkbp:clinical_trial ongoing research
cytogenetic abnormalities
high proliferation index
extramedullary disease
gptkbp:first_described_by 1950s
gptkbp:genetic_diversity T P53 gene
BC L6 gene
MYC gene
https://www.w3.org/2000/01/rdf-schema#label Burkitt leukemia
gptkbp:is_characterized_by rapid tumor growth
gptkbp:is_often_used_in gptkb:Africa
gptkb:Person
gptkb:New_Guinea
gptkbp:named_after Dr. Denis Burkitt
gptkbp:risk_factor malaria
immunosuppression
HIV infection
gptkbp:social_responsibility blood tests
imaging studies
more common in males
biopsy
depends on stage at diagnosis
good with treatment
depends on response to treatment
can be curable
higher incidence in equatorial Africa
rare in adults
gptkbp:symptoms weight loss
abdominal pain
fever
night sweats
swollen lymph nodes
gptkbp:treatment gptkb:vaccine
radiation therapy
chemotherapy
targeted therapy
stem cell transplant
maintenance therapy
CNS prophylaxis
intensive chemotherapy regimens
gptkbp:type_of gptkb:non-Hodgkin_lymphoma
endemic Burkitt lymphoma
immunodeficiency-associated Burkitt lymphoma
sporadic Burkitt lymphoma